Treatment of breast cancer cells with THC puts stress on the ER and downregulates cyclin-dependent kinase 1 (CDK1) and cell division cycle (Cdc2), causing arrested G2-M transition [155]. This evidence concerns the gene CDK1 and breast carcinoma.